Mizuho Securities USA LLC Buys 84,897 Shares of Humana Inc. (NYSE:HUM)

Mizuho Securities USA LLC lifted its stake in Humana Inc. (NYSE:HUM) by 914.2% during the third quarter, Holdings Channel.com reports. The fund owned 94,183 shares of the insurance provider’s stock after buying an additional 84,897 shares during the period. Mizuho Securities USA LLC’s holdings in Humana were worth $29,832,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of HUM. Pzena Investment Management LLC grew its stake in Humana by 538.7% in the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock valued at $866,250,000 after purchasing an additional 1,955,375 shares in the last quarter. Davis Selected Advisers grew its stake in shares of Humana by 16.1% in the second quarter. Davis Selected Advisers now owns 2,311,362 shares of the insurance provider’s stock valued at $863,640,000 after buying an additional 321,233 shares in the last quarter. Marshall Wace LLP increased its holdings in Humana by 118.9% during the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after buying an additional 774,085 shares during the last quarter. Legal & General Group Plc raised its position in Humana by 2.1% during the second quarter. Legal & General Group Plc now owns 1,183,985 shares of the insurance provider’s stock worth $442,396,000 after acquiring an additional 24,842 shares in the last quarter. Finally, Ontario Teachers Pension Plan Board lifted its stake in Humana by 11,647.2% in the first quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock valued at $367,342,000 after acquiring an additional 1,050,459 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently weighed in on HUM shares. UBS Group lowered their price objective on shares of Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. KeyCorp initiated coverage on Humana in a research report on Friday, October 11th. They set a “sector weight” rating on the stock. Piper Sandler lowered Humana from an “overweight” rating to a “neutral” rating and dropped their price objective for the company from $392.00 to $274.00 in a research note on Thursday, October 3rd. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and lifted their target price for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. Finally, Truist Financial dropped their price target on Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research note on Friday, October 11th. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $315.86.

Humana Price Performance

Shares of NYSE:HUM opened at $275.67 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $33.19 billion, a PE ratio of 24.42, a PEG ratio of 2.29 and a beta of 0.52. The firm has a 50 day moving average of $281.36 and a 200-day moving average of $331.61. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $527.18.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. On average, equities research analysts predict that Humana Inc. will post 15.83 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio is presently 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.